Instructions for Thioctacid HR (Thioctic acid)
English product name
Thioctacid® HR
Release form
Coated tablets
Description:
The tablets, which are coated with a film sheath of yellow-green colour, are oblong and double-convex.
1 tab.
α-lipoic acid 600 mg
Auxiliary substances: Hyprolose low-substituted - 157 mg, hyprolose - 20 mg, magnesium stearate - 24 mg.
Film sheath composition:
hypromellose - 15.8 mg, macrogol 6000 - 4.7 mg, titanium dioxide - 4 mg, talc - 2.02 mg, aluminum lacquer based on the dye quinoline yellow - 1.32 mg, aluminum lacquer based on indigocarmine - 0.16 mg.
ATC codes
A16AX01 Thioctic acid
Clinical-pharmacological groups / Group affiliation
Anti-oxidant drug regulating carbohydrate and lipid metabolism
Active substance
α-lipoic acid
Pharmacotherapy group
Metabolic agent
Storage Conditions
List B. The drug should be stored in a place inaccessible to children at a temperature not higher than 25 ° C.
Best before date
Shelf life is 5 years.
Testimony Thioctacid:
- diabetic polyneuropathy;
- alcoholic polyneuropathy.
How to take the drug Thioctacid:
The insides are given at 600 mg (one tabb.) once per day. The tablets take on an empty stomach, thirty minutes before breakfast, without chewing and drinking water.
In severe cases, treatment is initiated with the administration of a solution for the administration of Tiocticide® T for two to four weeks, then the patient is transferred to the treatment with the preparation Tiocticide® BV.
Pharmacological effect Thioctacid:
Metabolic drug. Thiotic (α-lipoic) acid is found in the human body, where it acts as a coenzyme in the oxidative phosphorylation reactions of pyruvic acid and alpha-keto acids. Thiotic acid is an endogenous antioxidant, and is biochemically similar to B-group vitamins.
Thiotic acid helps protect the cell from the toxic effects of free radicals that occur in metabolism; it also defuses exogenous toxic compounds that have entered the body. Thiotic acid increases the concentration of the endogenous antioxidant glutathione, which leads to a reduction in the expression of symptoms of polyneuropathy.
The preparation has a hepatoprotective, hypolipidemic, hypocholesterolemic, hypoglycemic effect; improves neuronal trophic. The synergistic action of thiotic acid and insulin results in an increase in glucose utilization.
Terms of Sale
The drug is prescription.
Use in children
Contraindication: Childhood and adolescence (clinical data on drug use in children and adolescents are lacking).
Nosology Thioctacid (ICD codes)
G62.1
Alcoholic polyneuropathy
G63.2
Diabetic polyneuropathy
